155 related articles for article (PubMed ID: 21897025)
1. An efficient and novel screening model for assessing the bioactivity of extracts against multidrug-resistant Pseudomonas aeruginosa using Caenorhabditis elegans.
Zhou YM; Shao L; Li JA; Han LZ; Cai WJ; Zhu CB; Chen DJ
Biosci Biotechnol Biochem; 2011; 75(9):1746-51. PubMed ID: 21897025
[TBL] [Abstract][Full Text] [Related]
2. Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection.
Dharmalingam K; Tan BK; Mahmud MZ; Sedek SA; Majid MI; Kuah MK; Sulaiman SF; Ooi KL; Khan NA; Muhammad TS; Tan MW; Shu-Chien AC
J Ethnopharmacol; 2012 Jan; 139(2):657-63. PubMed ID: 22193176
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of Pseudomonas aeruginosa virulence by medicinal plants in a Caenorhabditis elegans model system.
Adonizio A; Leal SM; Ausubel FM; Mathee K
J Med Microbiol; 2008 Jul; 57(Pt 7):809-813. PubMed ID: 18566137
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans.
Kirienko NV; Cezairliyan BO; Ausubel FM; Powell JR
Methods Mol Biol; 2014; 1149():653-69. PubMed ID: 24818940
[TBL] [Abstract][Full Text] [Related]
5. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
[TBL] [Abstract][Full Text] [Related]
6. Development, Optimization, and Validation of a High Throughput Screening Assay for Identification of Tat and Type II Secretion Inhibitors of
Massai F; Saleeb M; Doruk T; Elofsson M; Forsberg Å
Front Cell Infect Microbiol; 2019; 9():250. PubMed ID: 31355152
[TBL] [Abstract][Full Text] [Related]
7. Novel Immune Modulators Enhance
Hummell NA; Revtovich AV; Kirienko NV
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408224
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of Elaeagnus umbellata (Thunb.) a medicinal plant from Pakistan.
Sabir MS; Ahmad DS; Hussain IM; Tahir KM
Saudi Med J; 2007 Feb; 28(2):259-63. PubMed ID: 17268691
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistant bacteria are sensitive to Euphorbia prostrata and six others Cameroonian medicinal plants extracts.
Voukeng IK; Beng VP; Kuete V
BMC Res Notes; 2017 Jul; 10(1):321. PubMed ID: 28743314
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening for novel anti-infectives using a C. elegans pathogenesis model.
Conery AL; Larkins-Ford J; Ausubel FM; Kirienko NV
Curr Protoc Chem Biol; 2014 Mar; 6(1):25-37. PubMed ID: 24652621
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP
Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
[No Abstract] [Full Text] [Related]
12. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
Hill L; Veli N; Coote PJ
Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354
[TBL] [Abstract][Full Text] [Related]
13. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector.
Rasmussen TB; Bjarnsholt T; Skindersoe ME; Hentzer M; Kristoffersen P; Köte M; Nielsen J; Eberl L; Givskov M
J Bacteriol; 2005 Mar; 187(5):1799-814. PubMed ID: 15716452
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of selected medicinal plants against multiple antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu, India.
Narayanan AS; Raja SS; Ponmurugan K; Kandekar SC; Natarajaseenivasan K; Maripandi A; Mandeel QA
Benef Microbes; 2011 Sep; 2(3):235-43. PubMed ID: 21986363
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for multidrug-resistant nonfermenters.
Briceño DF; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
[TBL] [Abstract][Full Text] [Related]
16. 'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa.
Tateda K; Ishii Y; Matsumoto T; Yamaguchi K
Scand J Infect Dis; 2006; 38(4):268-72. PubMed ID: 16709527
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial properties of traditionally used Indian medicinal plants.
Aqil F; Ahmad I
Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):79-92. PubMed ID: 17440624
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel antimicrobials using a live-animal infection model.
Moy TI; Ball AR; Anklesaria Z; Casadei G; Lewis K; Ausubel FM
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10414-10419. PubMed ID: 16801562
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESbetaL-producing multidrug-resistant enteric bacteria.
Ahmad I; Aqil F
Microbiol Res; 2007; 162(3):264-75. PubMed ID: 16875811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
